(±)-Methyldopa
-
(±)-Methyldopa
structure -
-
CAS No:
55-40-3
-
Formula:
C10H13NO4
-
Chemical Name:
(±)-Methyldopa
-
Synonyms:
Tyrosine,3-hydroxy-α-methyl-;Alanine,3-(3,4-dihydroxyphenyl)-2-methyl-;3-Hydroxy-α-methyltyrosine;(±)-Methyldopa;Racemic α-methyldopa;DL-α-Methyl DOPA;(±)-α-Methyldopa;DL-Methyldopa;Metholes;Mulfasin;DL-2-Methyl-3-(3,4-dihydroxyphenyl)alanine;DL-α-Methyl-3-(3,4-dihydroxyphenyl)alanine;2-(3,4-Dihydroxybenzyl)-2-aminopropanoic acid;3-Hydroxy-α-methyl-DL-tyrosine;2-Amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid;2-Azaniumyl-3-(3,4-dihydroxyphenyl)-2-methylpropanoate;555-29-3
- Categories:
-
CAS No:
Description
Grey Solid
3-Hydroxy-alpha-methyl-DL-tyrosine is a monocarboxylic acid and a member of benzenes.|An alpha-2 adrenergic agonist that has both central and peripheral nervous system effects. Its primary clinical use is as an antihypertensive agent.
(±)-Methyldopa Basic Attributes
211.214
211.21
209-088-7
169916
C - Cardiovascular system
2922509090
Characteristics
103.78000
0.13
1.4±0.1 g/cm3
299-300.5 °C (decomp)
441.6±45.0 °C at 760 mmHg
220.9±28.7 °C
1.635
Soluble in isopropanol, ethanol, and water.
Methyldopa oral suspension should be stored in tight, light-resistant containers at a temperature less than 26 deg C and protected from freezing. Methyldopa tablets should be stored in well-closed containers at a temperature less than 40 deg C, preferably at 15-30 deg C.
Safety Information
3
36
S26-S37/39
Xi
Methyldopa is decomposed by oxidizing agents.
P264, P280, P302+P352, P305+P351+P338, P321, P332+P313, P337+P313, P362
H315
|Warning|H315 (19.15%): Causes skin irritation [Warning Skin corrosion/irritation]|P264, P280, P302+P352, P305+P351+P338, P321, P332+P313, P337+P313, and P362|Aggregated GHS information provided by 47 companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Drug Information
Compounds that bind to and activate ADRENERGIC ALPHA-2 RECEPTORS. (See all compounds classified as Adrenergic alpha-2 Receptor Agonists.)|Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here. (See all compounds classified as Sympatholytics.)|Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
Aldomet
(±)-Methyldopa Use and Manufacturing
Antihypertensive agent
L-Tyrosine, 3-hydroxy-.alpha.-methyl-: INACTIVE
Computed Properties
Molecular Weight:211.21
XLogP3:-1.9
Hydrogen Bond Donor Count:4
Hydrogen Bond Acceptor Count:5
Rotatable Bond Count:3
Exact Mass:211.08445790
Monoisotopic Mass:211.08445790
Topological Polar Surface Area:104
Heavy Atom Count:15
Complexity:246
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Learn More Other Chemicals
-
4,4′-(1,2-Diazenediyl)bis[N,N,N-trimethylbenzenaminium]
21704-61-0
-
N-(4-Chloro-2-methylphenyl)formamide
21787-81-5
-
Basic Blue 8
2185-87-7
-
3-tert-butyl-5-chloro-2-hydroxy-N-(2-nitrosophenyl)benzamide Formula
21889-00-9
-
1-Phenylcyclohexylamine Formula
2201-24-3
-
6-Hydroxymelatonin Formula
2208-41-5
-
Pyrrocaine Structure
2210-77-7
-
2-amino-N-(4-ethoxyphenyl)ethanesulfonamide Structure
22103-30-6
-
What is Bufeniode
22103-14-6
-
What is 4-(2-Quinolinyl)benzenamine
22191-97-5